GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

55 hedge funds and large institutions have $53.9M invested in Galectin Therapeutics in 2014 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
55
Holders Change
+22
Holders Change %
+66.67%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
15
Reduced
5
Closed
4
Calls
$3.36M
Puts
$8.65M
Net Calls
-$5.3M
Net Calls Change
-$4.74M

Top Buyers

1
BBA
1
Baker Bros. Advisors
New York
$7.66M
2
CAM
2
Cormorant Asset Management
Massachusetts
$5.33M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$4.03M
4
MP
4
Mangrove Partners
Connecticut
$3.06M
5
EI
5
EAM Investors
California
$2.48M

Top Sellers

1
CCA
1
Catalyst Capital Advisors
New York
$0
2
Neuberger Berman Group
2
Neuberger Berman Group
New York
$2.47M
3
DADC
3
D.A. Davidson & Co
Montana
$2.31M
4
WAM
4
Wolverine Asset Management
Illinois
$0
5
LOM
5
Loeb Offshore Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$2K 100 -12 -11%
PSI
52
Pinnacle Summer Investments
Virginia
$2K 167 – –
Barclays
53
Barclays
United Kingdom
$1K 69 -3,231 -98%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 157 – –
CCA
55
Catalyst Capital Advisors
New York
– – -204,000 Closed
WAM
56
Wolverine Asset Management
Illinois
– – -55,439 Closed
LOM
57
Loeb Offshore Management
New York
– – -11,179 Closed
MWP
58
MYCIO Wealth Partners
Pennsylvania
– – -2,000 Closed
Citadel Advisors
59
Citadel Advisors
Florida
– – – –
BlackRock
60
BlackRock
New York
$0 3 +3 New
1 2
3